New clinical trials in Bulgaria: 291 since Nov 2024

Name: New clinical trials in Bulgaria
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Bulgaria: 291 rows for $14.55, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/bulgaria, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

291 clinical studies with a site in Bulgaria were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 266 have an industry sponsor and 188 are recruiting or about to. The newest, NCT07919405, was posted on November 5, 2026: A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living... (Novo Nordisk A/S).

The request: Every new clinical trial with a site in Bulgaria, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

291New trials
266Industry sponsored
188Recruiting or not yet
November 5, 2026Latest posted

Newest trials

The newest 100 of 291, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 5, 2026	NCT07919405	A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Hypertension, Obesity	1,408	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany...	clinicaltrials.gov
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
November 2, 2026	NCT07908420	Accelerated Dual-Protocol rTMS for Refractory Trigeminal Neuralgia	Galileo Medical Center	Observational	Completed	Pain Management, Psychiatric Comorbidities	192	Bulgaria	clinicaltrials.gov
October 28, 2026	NCT07900464	The NUVASCULAR HARBOR Occlusion Device EU Study	Nuvascular Inc	Not applicable	Not yet recruiting	Intracranial Arterial Aneurysm	30	Austria, Bulgaria	clinicaltrials.gov
October 21, 2026	NCT07885891	Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia	Wockhardt	Phase 3	Not yet recruiting	Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)	324	Bosnia and Herzegovina, Bulgaria, Croatia, France, Georgia, Greece, India...	clinicaltrials.gov
October 16, 2026	NCT07877844	Prevalence, Clinical Characteristics and Treatment of Bulgarian Patients With Resistant Hypertension	Medical University of Sofia	Observational	Completed	Resistant Hypertension, Controlled Hypertension	256	Bulgaria	clinicaltrials.gov
October 13, 2026	NCT07870369	Cardiovascular Risk in Patients With Primary Hyperparathyroidism	Medical University of Sofia	Observational	Completed	Heart Failure, Atrial Fibrillation (AF), Arrhythmia, Coronary Artery Disease, Hypertension (HTN)	77	Bulgaria	clinicaltrials.gov
October 6, 2026	NCT07861100	A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Cardiovascular Risk, Obesity	8,500	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark...	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 30, 2026	NCT07850453	Vortosiran for VTE Prevention	Ribocure Pharmaceuticals AB	Phase 2	Not yet recruiting	Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)	150	Bulgaria, France, Poland, Romania	clinicaltrials.gov
September 25, 2026	NCT07841301	PRF Versus Emdogain for Class II Furcation Defects of Mandibular Molars	Medical University of Sofia	Not applicable	Completed	Peridontal Disease, Furcation Defects	21	Bulgaria	clinicaltrials.gov
September 3, 2026	NCT07801573	Immediate Molar Implants With Customized Healing Abutments in Different Post-Extraction Socket Classes	Plovdiv Medical University	Observational	Recruiting	Tooth Loss, Alveolar Bone Loss, Jaw, Edentulous, Partially	60	Bulgaria	clinicaltrials.gov
September 1, 2026	NCT07797335	AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People...	Novo Nordisk A/S	Phase 3	Recruiting	Type 2 Diabetes, Cardiovascular Risk	1,778	Argentina, Brazil, Bulgaria, Canada, China, Czechia, Germany, Greece, India...	clinicaltrials.gov
August 27, 2026	NCT07789015	A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies	Boehringer Ingelheim	Phase 3	Not yet recruiting	Idiopathic Inflammatory Myopathies	270	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 25, 2026	NCT07784725	A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2...	AstraZeneca	Phase 3	Recruiting	Obesity or Overweight	2,500	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, France...	clinicaltrials.gov
August 24, 2026	NCT07783282	A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer	Astellas Pharma Global Development, Inc.	Phase 1	Recruiting	Prostate Cancer	56	Bulgaria	clinicaltrials.gov
August 18, 2026	NCT07770958	Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension	Medical University of Sofia	Observational	Active not recruiting	Essential Arterial Hypertension, Circadian Disruption	200	Bulgaria	clinicaltrials.gov
August 18, 2026	NCT07770841	Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight	Novo Nordisk A/S	Phase 3	Recruiting	Overweight, Obesity	450	Belgium, Bulgaria, Denmark, France, Greece, Netherlands, Poland, Spain, Sweden...	clinicaltrials.gov
August 12, 2026	NCT07761117	A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF	AstraZeneca	Phase 3	Recruiting	Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)	6,950	Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 10, 2026	NCT07754240	A Clinical Investigational Study of Ankura™ II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm	Lifetech Scientific (Shenzhen) Co., Ltd.	Not applicable	Recruiting	Abdominal Aortic Aneurysms (AAA)	45	Bulgaria	clinicaltrials.gov
August 10, 2026	NCT07753993	A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.	AstraZeneca	Phase 3	Recruiting	Chronic Kidney Disease	7,000	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark...	clinicaltrials.gov
August 4, 2026	NCT07743580	A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease	Shionogi	Phase 3	Recruiting	SARS-CoV-2	2,000	Bulgaria, Japan, United States	clinicaltrials.gov
August 3, 2026	NCT07741656	A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)	Andromeda Surgical	Not applicable	Recruiting	BPH (Benign Prostatic Hyperplasia), HoLEP (Holmium Laser Enucleation of Prostate)	50	Bulgaria, Chile, New Zealand	clinicaltrials.gov
July 28, 2026	NCT07731490	Early Detection and IntervenTion in Heart Failure	University Hospital, Basel, Switzerland	Not applicable	Recruiting	Heart Failure (HF)	18,000	Austria, Bulgaria, Germany, Italy, Netherlands, South Korea, Spain...	clinicaltrials.gov
July 22, 2026	NCT07718828	Laparoscopic Nissen Versus Toupet Fundoplication for Hiatal Hernia.	Sofia Med Hospital	Not applicable	Recruiting	Hiatal Hernia, Paraesophageal, Hiatal Hernia Large, Hiatal Hernia With Gastroesophageal Reflux Disease	200	Bulgaria	clinicaltrials.gov
July 17, 2026	NCT07710144	Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances	Plovdiv Medical University	Not applicable	Not yet recruiting	Plaque-Induced Gingivitis, Dental Plaque Accumulation, Halitosis	90	Bulgaria	clinicaltrials.gov
July 9, 2026	NCT07691970	Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From...	AstraZeneca	Phase 3	Recruiting	Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus	1,072	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
July 7, 2026	NCT07687784	A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia	AFT Pharmaceuticals, Ltd.	Phase 3	Not yet recruiting	Iron Deficiency Anemia (IDA)	1,366	Bulgaria, Poland, Romania, United States	clinicaltrials.gov
July 7, 2026	NCT07686263	Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia	Karuna Therapeutics, Inc., a Bristol Myers Squibb company	Phase 3	Recruiting	Schizophrenia	472	Argentina, Bulgaria, Czechia, Poland, Romania, Spain, United States	clinicaltrials.gov
July 2, 2026	NCT07681271	A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea...	Novartis Pharmaceuticals	Phase 2	Recruiting	Papulopustular Rosacea	100	Bulgaria, Canada, China, Germany, Singapore, South Korea, Spain, United States	clinicaltrials.gov
June 24, 2026	NCT07666490	BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA...	Chiesi Farmaceutici S.p.A.	Phase 4	Recruiting	Asthma	644	Bulgaria	clinicaltrials.gov
June 24, 2026	NCT07665853	Optimizing the Use of Aspirin for the Prevention of Preeclampsia	Hospital Universitari Vall d'Hebron Research Institute	Phase 3	Not yet recruiting	Preeclampsia	15,160	Austria, Bulgaria, Ghana, Senegal, Spain, The Gambia, United Kingdom	clinicaltrials.gov
June 24, 2026	NCT07664553	A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	600	Australia, Bulgaria, Canada, China, Czechia, Germany, India, Japan, Malaysia...	clinicaltrials.gov
June 23, 2026	NCT07662213	A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	1,200	Argentina, Australia, Brazil, Bulgaria, Canada, China, Germany, Hungary, Italy...	clinicaltrials.gov
June 23, 2026	NCT07662135	A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease	900	Bulgaria, China, Denmark, Germany, India, Japan, Malaysia, Mexico, Spain...	clinicaltrials.gov
June 17, 2026	NCT07652658	A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.	AstraZeneca	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis (IPF)	359	Argentina, Australia, Bulgaria, Canada, Chile, China, Denmark, France, Germany...	clinicaltrials.gov
June 12, 2026	NCT07644065	Kynurenic Acid and Serotonin as Perioperative Neuroinflammatory Biomarkers in Sequential Third Molar Surgery	Plovdiv Medical University	Not applicable	Completed	Impacted Third Molar, Postoperative Pain, Neuroinflammation, Anxiety	40	Bulgaria	clinicaltrials.gov
June 4, 2026	NCT07625644	BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)	SystImmune Inc.	Phase 3	Recruiting	Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung...	550	Australia, Bulgaria, Canada, Czechia, France, Georgia, Germany, Greece...	clinicaltrials.gov
June 4, 2026	NCT07625215	A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation	Bayer	Phase 2	Recruiting	Atrial Fibrillation	360	Belgium, Bulgaria, Germany, Hungary, Italy, Netherlands, Poland, United States	clinicaltrials.gov
June 3, 2026	NCT07624305	A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)	AstraZeneca	Phase 3	Recruiting	Renal Insufficiency, Chronic	2,800	Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece...	clinicaltrials.gov
June 3, 2026	NCT07623161	A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib	Takeda	Phase 3	Recruiting	Myelofibrosis, Anemia	324	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile...	clinicaltrials.gov
June 3, 2026	NCT07622238	IAU Percutaneous Nephrolithotripsy Study	Foundation Endourology	Observational	Completed	Urolithiasis, Kidney Calculi	4,000	Bulgaria	clinicaltrials.gov
June 1, 2026	NCT07619131	A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in...	AstraZeneca	Phase 3	Recruiting	Hypercholesterolaemia	600	Bulgaria, Canada, Denmark, Germany, Hungary, Israel, Poland, Spain, Ukraine...	clinicaltrials.gov
May 20, 2026	NCT07599813	A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis	Apollo Therapeutics Ltd	Phase 2	Recruiting	Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis...	280	Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Spain, United States	clinicaltrials.gov
May 19, 2026	NCT07596849	A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.	argenx	Phase 3	Recruiting	Graves Disease	230	Belgium, Bulgaria, Canada, Denmark, Georgia, Germany, Greece, Italy, Japan...	clinicaltrials.gov
May 11, 2026	NCT07577856	A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis	Janssen Research & Development, LLC	Phase 3	Recruiting	Colitis, Ulcerative	644	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
May 5, 2026	NCT07567001	A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Heart Failure	5,610	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark...	clinicaltrials.gov
May 4, 2026	NCT07564414	A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or...	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Type 2 Diabetes	2,500	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France...	clinicaltrials.gov
April 30, 2026	NCT07559175	A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.	Aimmune Nestlé Health Science US R&D, LLC	Phase 2	Recruiting	Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases	66	Bulgaria, Hungary, Italy, Poland, Spain, United Kingdom, United States	clinicaltrials.gov
April 30, 2026	NCT07558668	A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis	Sitryx Therapeutics Ltd	Phase 1	Recruiting	Moderate to Severe Atopic Dermatitis	149	Bulgaria, Denmark, Germany, Ireland, United Kingdom, United States	clinicaltrials.gov
April 17, 2026	NCT07535190	Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment	Nadezhda Women's Health Hospital	Not applicable	Recruiting	IVF Patients, Female Infertility	50	Bulgaria	clinicaltrials.gov
April 16, 2026	NCT07533955	A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis	Jade Biosciences, Inc.	Phase 1	Recruiting	Rhematoid Arthritis	36	Bulgaria, Georgia, Germany, Moldova, Romania, Ukraine	clinicaltrials.gov
April 8, 2026	NCT07517263	An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen...	Novartis Pharmaceuticals	Phase 3	Active not recruiting	Cardiovascular Disease and Lipoprotein(a)	5,700	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
April 3, 2026	NCT07509307	AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis...	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Overweight, Osteoarthritis, Knee	400	Australia, Bulgaria, Canada, Denmark, Greece, Italy, Poland, Puerto Rico...	clinicaltrials.gov
March 31, 2026	NCT07503210	AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss	Novo Nordisk A/S	Phase 3	Active not recruiting	Obesity	606	Argentina, Australia, Belgium, Bulgaria, Denmark, France, Germany, Italy...	clinicaltrials.gov
March 27, 2026	NCT07497087	A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis	Boehringer Ingelheim	Phase 3	Recruiting	Systemic Sclerosis	448	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
March 25, 2026	NCT07493304	Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers	Regeneron Pharmaceuticals	Phase 3	Recruiting	Venous Thromboembolism (VTE)	1,600	Bulgaria, Japan, Romania, South Korea, United States	clinicaltrials.gov
March 25, 2026	NCT07493278	Er,Cr:YSGG Laser Versus Conventional Preparation for Minimally Invasive Caries Removal	Medical University of Sofia	Not applicable	Completed	Dental Caries	32	Bulgaria	clinicaltrials.gov
March 19, 2026	NCT07481630	A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight...	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Knee Osteoarthritis (OA)	400	Australia, Bulgaria, Canada, Denmark, Greece, Italy, Poland, Spain, Turkey...	clinicaltrials.gov
March 16, 2026	NCT07472517	DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and...	Boehringer Ingelheim	Phase 3	Recruiting	Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)	670	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
March 12, 2026	NCT07467993	Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia	Novartis Pharmaceuticals	Phase 2	Recruiting	Schizophrenia	142	Bulgaria, United States	clinicaltrials.gov
March 10, 2026	NCT07461220	Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy	Integrative Research Laboratories AB	Phase 1/2	Recruiting	PARKINSON DISEASE (Disorder), Apathy, Safety	75	Bulgaria, Germany, Poland, Spain	clinicaltrials.gov
March 10, 2026	NCT07459660	An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis	MapLight Therapeutics	Phase 2	Enrolling by invitation	Psychosis Associated With Alzheimer's Disease	210	Bulgaria, France, United States	clinicaltrials.gov
March 9, 2026	NCT07456891	Remibrutinib Open Label Roll-over Post-trial Access Protocol	Novartis Pharmaceuticals	Phase 3	Recruiting	Indication of the Parent Protocol	650	Bulgaria, Canada, Colombia, Czechia, France, Poland, South Korea, Spain, Vietnam	clinicaltrials.gov
March 5, 2026	NCT07452692	A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects	Corium Innovations, Inc.	Phase 1	Completed	Major Depressive Disorder (MDD)	232	Bulgaria	clinicaltrials.gov
March 5, 2026	NCT07450833	Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers	Benfovir AG	Phase 1	Completed	Healthy Volunteers	48	Bulgaria	clinicaltrials.gov
March 2, 2026	NCT07441642	A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related...	Novartis Pharmaceuticals	Phase 2	Recruiting	Geographic Atrophy Secondary to Age-related Macular Degeneration	272	Argentina, Australia, Brazil, Bulgaria, Canada, China, Colombia, Czechia...	clinicaltrials.gov
February 27, 2026	NCT07438496	A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus	Janssen Research & Development, LLC	Phase 3	Recruiting	Lupus Erythematosus, Systemic	600	Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland...	clinicaltrials.gov
February 24, 2026	NCT07431294	A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary...	Bayer	Phase 1	Not yet recruiting	Stable Coronary Artery Disease	36	Bulgaria, Germany	clinicaltrials.gov
February 23, 2026	NCT07428499	Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)	ADARx Pharmaceuticals, Inc.	Phase 3	Recruiting	Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE	90	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, China, Croatia...	clinicaltrials.gov
February 23, 2026	NCT07425704	Probiotics, Antibiotics and the Post-Antibiotic Microbiota	Cultech Ltd	Not applicable	Not yet recruiting	Probiotic, Microbiome	50	Bulgaria	clinicaltrials.gov
February 20, 2026	NCT07422480	A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need...	Takeda	Phase 3	Recruiting	Myelodysplastic Syndrome, Anemia	300	Argentina, Australia, Belgium, Brazil, Bulgaria, France, Germany, Greece...	clinicaltrials.gov
February 17, 2026	NCT07415551	Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines	Yuhan Corporation	Phase 2	Recruiting	Allergic Diseases, Chronic Spontaneous Urticaria (CSU)	150	Bulgaria, China, Poland, South Korea	clinicaltrials.gov
February 13, 2026	NCT07409181	A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)	Boehringer Ingelheim	Phase 2	Recruiting	Systemic Lupus Erythematosus	405	Argentina, Australia, Brazil, Bulgaria, China, Colombia, Croatia, Germany...	clinicaltrials.gov
February 10, 2026	NCT07400653	A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Pfizer	Phase 3	Active not recruiting	Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes	1,078	Argentina, Bulgaria, Canada, Czechia, Germany, Poland, Romania, Slovakia...	clinicaltrials.gov
February 10, 2026	NCT07400107	AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	1,000	Argentina, Brazil, Bulgaria, Croatia, Germany, Hungary, India, Mexico, Poland...	clinicaltrials.gov
February 3, 2026	NCT07384975	A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa	Navigator Medicines, Inc.	Phase 2	Recruiting	Hidradenitis Suppurativa (HS)	150	Bulgaria, Canada, Georgia, Germany, Hungary, Poland, Romania, United States	clinicaltrials.gov
January 23, 2026	NCT07364383	Probiotics for Women	Cultech Ltd	Not applicable	Completed	Probiotic, Microbiome, Wellbeing	40	Bulgaria	clinicaltrials.gov
January 23, 2026	NCT07363694	A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease	Pfizer	Phase 2/3	Recruiting	Moderate to Severe Chronic Obstructive Pulmonary Disease	1,156	Argentina, Australia, Bulgaria, Canada, China, Czechia, France, Germany...	clinicaltrials.gov
January 23, 2026	NCT07361510	A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung...	Bristol-Myers Squibb	Phase 3	Recruiting	Non-Small Cell Lung Cancer (NSCLC)	750	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
January 23, 2026	NCT07361497	A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III...	Bristol-Myers Squibb	Phase 3	Recruiting	Non-small Cell Lung Cancer (NSCLC)	850	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
January 23, 2026	NCT07361302	A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen...	Boehringer Ingelheim	Phase 3	Recruiting	Acute Ischemic Stroke	1,325	Argentina, Australia, Bulgaria, China, Greece, Hungary, India, Indonesia...	clinicaltrials.gov
January 22, 2026	NCT07358429	CPAP Therapy and Atrial Fibrillation Recurrence in OSA	Medical University of Sofia	Observational	Active not recruiting	Obstructive Sleep Apnea (OSA), Atrial Fibrillation (Paroxysmal)	91	Bulgaria	clinicaltrials.gov
January 22, 2026	NCT07357766	A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight	Novo Nordisk A/S	Phase 3	Withdrawn	Overweight, Obesity	0	Bulgaria, Denmark, Greece, Hungary, Malaysia, Poland, Portugal, Romania...	clinicaltrials.gov
January 21, 2026	NCT07355218	A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)	EMD Serono Research & Development Institute, Inc.	Phase 3	Recruiting	Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus	202	Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Germany, Israel...	clinicaltrials.gov
January 12, 2026	NCT07332481	A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease	EMD Serono Research & Development Institute, Inc.	Phase 3	Recruiting	Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)	202	Australia, Belgium, Brazil, Bulgaria, China, France, Germany, Israel, Italy...	clinicaltrials.gov
January 12, 2026	NCT07331831	Research on Attitudes, Confidence, and Practical Skills in Performing Cardiopulmonary Resuscitation and Automated External Defibrillation...	First Three Minutes Foundation	Observational	Completed	Sudden Cardiac Arrest	656	Bulgaria	clinicaltrials.gov
January 8, 2026	NCT07326709	A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease	Novartis Pharmaceuticals	Phase 3	Recruiting	Huntington Disease	770	Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia...	clinicaltrials.gov
December 31, 2025	NCT07311850	Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity	Pfizer	Phase 3	Active not recruiting	Obesity and Overweight	3,578	Bulgaria, Canada, Czechia, Germany, Poland, Romania, Slovakia, Spain, United...	clinicaltrials.gov
December 24, 2025	NCT07301736	Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma	Chiesi Farmaceutici S.p.A.	Phase 2	Recruiting	Asthma	780	Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Latvia...	clinicaltrials.gov
December 24, 2025	NCT07300969	A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Draig Therapeutics Ltd	Phase 2	Recruiting	Major Depressive Disorder (MDD)	300	Bulgaria, Czechia, Poland, United Kingdom, United States	clinicaltrials.gov
December 23, 2025	NCT07299019	A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis	Zenas BioPharma (USA), LLC	Phase 3	Recruiting	Secondary Progressive Multiple Sclerosis	990	Australia, Belgium, Bulgaria, Croatia, Czechia, Estonia, France, Georgia...	clinicaltrials.gov
December 23, 2025	NCT07298330	A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)	Mirum Pharmaceuticals, Inc.	Phase 3	Active not recruiting	Chronic Hepatitis D Infection	80	Belgium, Bulgaria, Georgia, Hungary, Israel, Pakistan, Taiwan, Ukraine, United...	clinicaltrials.gov
December 17, 2025	NCT07290036	A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	UCB Biopharma SRL	Phase 1	Recruiting	Psoriatic Arthritis, Axial Spondyloarthritis	392	Bulgaria, Czechia, Germany, Poland, Slovakia, United States	clinicaltrials.gov
December 17, 2025	NCT07288489	Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require...	VarmX B.V.	Phase 3	Recruiting	Blood Loss, Surgical, Coagulation Disorder	800	Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Hungary, Italy...	clinicaltrials.gov
December 17, 2025	NCT07288398	LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2	Tenax Therapeutics, Inc.	Phase 3	Active not recruiting	Pulmonary Hypertension Associated With HFpEF	540	Argentina, Austria, Brazil, Bulgaria, Czechia, France, Germany, Hungary, Italy...	clinicaltrials.gov
December 17, 2025	NCT07288333	Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia	Neurocrine Biosciences	Phase 2	Recruiting	Schizophrenia	120	Bulgaria, Romania, United Kingdom	clinicaltrials.gov
December 17, 2025	NCT07287644	A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa	Bluefin Biomedicine, Inc.	Phase 2/3	Active not recruiting	Hidradenitis Suppurativa (HS)	210	Bulgaria, Canada, Czechia, Germany, Poland, Spain, United States	clinicaltrials.gov
December 16, 2025	NCT07286032	A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced...	Jiangsu HengRui Medicine Co., Ltd.	Phase 3	Recruiting	Patients With Chemotherapy-Induced Thrombocytopenia	150	Bulgaria, China, France, Italy, Poland, Romania, South Korea, Spain, Turkey...	clinicaltrials.gov
December 16, 2025	NCT07286006	A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)	Immunovant Sciences GmbH	Phase 2	Enrolling by invitation	Graves' Disease	372	Australia, Bulgaria, Czechia, Georgia, Hungary, Israel, Latvia, Poland, South...	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	25	October 1, 2026
Pfizer	14	February 10, 2026
Novo Nordisk A/S	13	November 5, 2026
Boehringer Ingelheim	11	November 4, 2026
Novartis Pharmaceuticals	10	July 2, 2026
Bristol-Myers Squibb	10	January 23, 2026
Medical University of Sofia	9	October 16, 2026
Sanofi	8	October 29, 2025
Neurocrine Biosciences	6	December 17, 2025
Plovdiv Medical University	5	September 3, 2026
Chiesi Farmaceutici S.p.A.	5	June 24, 2026
Takeda	5	June 3, 2026
Janssen Research & Development, LLC	5	May 11, 2026
Immunovant Sciences GmbH	5	December 16, 2025
Hoffmann-La Roche	5	December 16, 2025
AbbVie	5	November 17, 2025
GlaxoSmithKline	5	September 17, 2025
Bayer	4	June 4, 2026
Eli Lilly and Company	4	November 21, 2025
Amgen	4	June 25, 2025

Conditions

Condition group	New trials	Latest
Obesity	23	November 5, 2026
Overweight	15	August 25, 2026
Heart Failure	12	October 13, 2026
Hypertension	9	November 5, 2026
Diabetes Mellitus, Type 2	9	September 1, 2026
Asthma	9	June 24, 2026
Pulmonary Disease, Chronic Obstructive	9	January 23, 2026
Carcinoma, Non-Small-Cell Lung	9	January 23, 2026
Colitis, Ulcerative	8	May 11, 2026
Depressive Disorder, Major	8	March 5, 2026
Hidradenitis Suppurativa	8	February 3, 2026
Renal Insufficiency, Chronic	7	August 10, 2026
Lupus Erythematosus, Systemic	7	February 27, 2026
Lung Neoplasms	6	June 4, 2026
Dermatitis, Atopic	6	May 20, 2026
Atrial Fibrillation	5	October 13, 2026
Neoplasms	5	September 30, 2026
Schizophrenia	5	July 7, 2026
Cardiovascular Diseases	5	April 8, 2026
Angioedemas, Hereditary	5	February 23, 2026
Depression	5	December 24, 2025
Arthritis, Psoriatic	5	December 17, 2025
Arthritis, Rheumatoid	5	December 11, 2025
Breast Neoplasms	5	July 14, 2025
Skin Diseases	4	May 20, 2026

By phase

Phase	New trials	Latest
Phase 3	157	November 5, 2026
Phase 2	59	September 30, 2026
Not applicable	26	October 28, 2026
Observational	18	November 2, 2026
Phase 1	18	August 24, 2026
Phase 2/3	8	January 23, 2026
Phase 1/2	4	March 10, 2026
Phase 4	1	June 24, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.